The Asia Pacific Intravenous Infusion Pump Market would witness market growth of 9.9% CAGR during the forecast period (2021-2027).
With the increasing technological advancements, the intravenous infusion pumps market is estimated to fuel the market growth during the forecast period. These technological advancements in infusion pumps have developed medical care in hospitals and enabled patients to get all the required fluids on an outpatient basis or in a home medical setup, which helps them to get proper treatment and also live their daily lives, by using these smart intravenous infusion pumps. Along with that, these pumps help in preventing medication errors and minimize the risk of patient harm. There are many big companies, which are increasingly investing in the intravenous infusion pumps market. For example, vTitan, a Chennai-based healthcare company, in January 2018, unveiled the next generation of Syringe Infusion Pumps that are utilized for critical care in hospitals & homes for better, reliable, and safer infusion of drugs.
The growing cases of various chronic diseases are expected to boost the growth of the regional intravenous infusion pumps market. In addition, the rising expenditure of the governments of emerging nations like China, India, and Japan on the healthcare system is also bolstering the growth of the intravenous infusion pumps market in this region.
The high adoption of various advanced medical equipment is one of the key factors driving the market in this region. Along with that, the regional presence of many key players of the intravenous infusion pumps is also supporting the regional growth of the market. The emerging trend of home health care settings is also estimated to augment the regional growth of the intravenous infusion pumps market over the forecast period.
The China market dominated the Asia Pacific Home Healthcare Market by Country in 2020, thereby, achieving a market value of $129.2 million by 2027. The Japan market is showcasing a CAGR of 11.3% during (2021 - 2027). Additionally, The India market is anticipated to witness a CAGR of 11.3% during (2021 - 2027).
Based on Type, the market is segmented into Volumetric Infusion Pumps, Syringe Infusion Pumps and Patient Controlled Analgesia Infusion Pumps. Based on Application, the market is segmented into Oncology, Parenteral Nutrition, Analgesia/Pain Management and Others. Based on End User, the market is segmented into Hospitals & Clinics, Home Healthcare and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Intravenous Infusion Pump Market is Projected to reach USD 8.2 Billion by 2027, at a CAGR of 8.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, B. Braun Melsungen AG, Medtronic PLC, F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Baxter International, Inc., Terumo Corporation, Smiths Group PLC, Boston Scientific Corporation, and Micrel Medical Devices SA.
By Type
By Application
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 